Synthetic peptides derived from human MHC class I sequences delay allograft rejection in rodents and inhibit cell-mediated cytotoxicity in vivo and in vitro

Immunol Rev. 1996 Dec:154:5-20. doi: 10.1111/j.1600-065x.1996.tb00927.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Cytotoxicity, Immunologic / drug effects*
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • HLA-B Antigens / chemistry
  • HLA-B Antigens / pharmacology
  • Histocompatibility Antigens Class I / chemistry
  • Histocompatibility Antigens Class I / pharmacology*
  • Humans
  • Immunity, Cellular
  • Immunosuppressive Agents / chemical synthesis
  • Immunosuppressive Agents / pharmacology*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Peptides / chemical synthesis
  • Peptides / pharmacology*
  • Rodentia
  • Transplantation, Homologous / immunology

Substances

  • HLA-B Antigens
  • Histocompatibility Antigens Class I
  • Immunosuppressive Agents
  • Peptides